Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
21.99
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
NovoCure's Return On Capital Employed Overview
May 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
4 Analysts Have This to Say About NovoCure
May 16, 2023
Via
Benzinga
Should You Buy Novocure Stock Right Now?
May 05, 2023
Most Wall Street analysts think this stock will skyrocket. They could be right.
Via
The Motley Fool
NovoCure (NVCR) Q1 2023 Earnings Call Transcript
May 04, 2023
NVCR earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Novocure Stock Dips As Q1 Earnings Miss Estimates, Higher Costs Hurt Bottom Line
May 04, 2023
Via
Benzinga
NovoCure: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About NovoCure
March 17, 2023
Via
Benzinga
2 Best Defensive Stocks to Buy in March
March 08, 2023
These two defensive stocks should shine in the event of a marketwide correction.
Via
The Motley Fool
The 3 Most Promising Healthcare Tech Stocks for April 2023
April 26, 2023
The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
2 Stocks That Could Rebound and Rise 30% or More in 2023
March 10, 2023
They're down, but they aren't yet out.
Via
The Motley Fool
NovoCure Earnings Perspective: Return On Capital Employed
February 27, 2023
Via
Benzinga
Why NovoCure Stock Is Falling Today
February 23, 2023
Investors were looking for a stronger Q4 from the cancer company.
Via
The Motley Fool
NovoCure (NVCR) Q4 2022 Earnings Call Transcript
February 23, 2023
NVCR earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Novocure Stock Was so Healthy Today
February 15, 2023
There was good news from the laboratory on Hump Day.
Via
The Motley Fool
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Why Novocure Stock Is Sliding Today
January 19, 2023
Investors reacted negatively to the oncology treatment specialist's game of C-suite musical chairs.
Via
The Motley Fool
Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes
January 19, 2023
A series of unexpected C-suite changes sent shares diving again.
Via
Investor's Business Daily
Will Novocure Stock Sink or Soar in 2023?
January 19, 2023
The stock has both soared and sank already this year.
Via
The Motley Fool
Novocure Has Fallen More Than 20% Over Seven Days — Why It Fell From Grace
January 17, 2023
Shares have given back a chunk of their 69% single-day gain on a lung cancer study.
Via
Investor's Business Daily
Why Novocure Stock Is Sinking Today
January 09, 2023
The company provided a disappointing sneak peek at its Q4 results.
Via
The Motley Fool
Is NovoCure a Good Stock to Buy Right Now?
January 07, 2023
Successful clinical trial results recently pushed this stock more than 68% higher overnight -- but what about the road ahead?
Via
The Motley Fool
Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review
January 06, 2023
The major indexes rallied Friday on the jobs report and services data.
Via
Investor's Business Daily
Why Novocure Stock Is Flying High
January 06, 2023
Here's why Novocure stock popped over 68% on Jan. 5.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
Tesla, Amazon, Aehr, Silvergate, Novocure: Why These 5 Stocks Are Drawing Investors' Attention Today
January 05, 2023
Major Wall Street indices closed over 1% lower on Thursday, dragged by strong employment data which could nudge the Federal Reserve to continue its rate hikes.
Via
Benzinga
Why Shares of Zai Lab Soared This Week
January 05, 2023
A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.
Via
The Motley Fool
Dow Falls Over 200 Points; Walgreens Earnings Top Expectations
January 05, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 200 points on Thursday.
Via
Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.